{"title":"Hybrid Model: Deep Learning method for Early Detection of Alzheimer’s disease from MRI images","authors":"Anuradha Vashishtha, Anuja Kumar Acharya, Sujata Swain","doi":"10.13005/bpj/2739","DOIUrl":null,"url":null,"abstract":"Alzheimer's disease is a neurodegenerative brain disease that kills neurons. The global prevalence of the disease is gradually growing. In all leading countries, it is one of the senior citizens' leading causes of death. So, much research shows that early detection of illness is the most critical factor in improving patient care and treatment outcomes. Currently, AD is diagnosed by the manual study of magnetic resonance imaging, biomarker tests, and cognitive tests. Machine learning algorithms are used for automatic diagnosis. However, they have certain limits in terms of accuracy. Another issue is that models trained on class-unbalanced datasets often have poor results. Therefore, the main objective of the proposed work is to include a pre-processing method before the hybrid model to improve classification accuracy. This research presents a hybrid model based on a deep learning approach to detect Alzheimer’s disease. Which, we are using the SMOTE method to equally distribute the classes to prevent the issue of class imbalance. The hybrid model uses Inception V3 and Resnet50 to detect characteristics of Alzheimer's disease from magnetic resonance imaging. Finally, a dense layer of convolution neural network is used for classification. The hybrid approach achieves 99% accuracy in classifying MRI datasets, which is better than the old work. These results are better than existing approaches based on accuracy, specificity, sensitivity, and other characteristics.","PeriodicalId":9054,"journal":{"name":"Biomedical and Pharmacology Journal","volume":"38 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical and Pharmacology Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.13005/bpj/2739","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Alzheimer's disease is a neurodegenerative brain disease that kills neurons. The global prevalence of the disease is gradually growing. In all leading countries, it is one of the senior citizens' leading causes of death. So, much research shows that early detection of illness is the most critical factor in improving patient care and treatment outcomes. Currently, AD is diagnosed by the manual study of magnetic resonance imaging, biomarker tests, and cognitive tests. Machine learning algorithms are used for automatic diagnosis. However, they have certain limits in terms of accuracy. Another issue is that models trained on class-unbalanced datasets often have poor results. Therefore, the main objective of the proposed work is to include a pre-processing method before the hybrid model to improve classification accuracy. This research presents a hybrid model based on a deep learning approach to detect Alzheimer’s disease. Which, we are using the SMOTE method to equally distribute the classes to prevent the issue of class imbalance. The hybrid model uses Inception V3 and Resnet50 to detect characteristics of Alzheimer's disease from magnetic resonance imaging. Finally, a dense layer of convolution neural network is used for classification. The hybrid approach achieves 99% accuracy in classifying MRI datasets, which is better than the old work. These results are better than existing approaches based on accuracy, specificity, sensitivity, and other characteristics.
期刊介绍:
Biomedical and Pharmacology Journal (BPJ) is an International Peer Reviewed Research Journal in English language whose frequency is quarterly. The journal seeks to promote research, exchange of scientific information, consideration of regulatory mechanisms that affect drug development and utilization, and medical education. BPJ take much care in making your article published without much delay with your kind cooperation and support. Research papers, review articles, short communications, news are welcomed provided they demonstrate new findings of relevance to the field as a whole. All articles will be peer-reviewed and will find a place in Biomedical and Pharmacology Journal based on the merit and innovativeness of the research work. BPJ hopes that Researchers, Research scholars, Academician, Industrialists etc. would make use of this journal for the development of science and technology. Topics of interest include, but are not limited to: Biochemistry Genetics Microbiology and virology Molecular, cellular and cancer biology Neurosciences Pharmacology Drug Discovery Cardiovascular Pharmacology Neuropharmacology Molecular & Cellular Mechanisms Immunology & Inflammation Pharmacy.